University of Oklahoma
Also known as: Barbara Carlson | Children's Hospital of Oklahoma | Children's Hospital Oklahoma University Medical Center | Lead Investigator for Ovarian Cohort A | Mark L. Wolraich | Mark L. Wolraich, M.D. | Obstetrics and Gynecology | Oklahoma Cardiovascular Research | Oklahoma University Cancer Institute | Oklahoma University Children's Hospital | Oklahoma University Health Science Center | Oklahoma University Health Sciences Center | OTRC, OU Children's Hospital Dept. of Pediatrics, OU Cancer Center | OU Dodge Family College of Arts and Sciences | OU Health Stephenson Cancer Center | OU Health, Stephenson Cancer Center | OUHSC | OUHSC and VAMC | Peggy and Charles Stephenson Oklahoma Cancer Center | Peggy Charles Stephenson Cancer Center | Professor, University of Oklahoma Health Sciences Center | Stephenson Cancer Center | Stephenson Cancer Center, University of Oklahoma Health Sciences Center | The University of Oklahoma | The University of Oklahoma, College of Dentistry, Division in Periodontics | The University of Oklahoma College of Pharmacy | The University of Oklahoma, Department of Pediatrics | The University of Oklahoma Health Sciences Center | Univeristy of Oklahoma | Univeristy of Oklahoma Health Sciences Center | University of Oklahoma | University of Oklahoma College of Medicine | University of Oklahoma Health Science Center | University of Oklahoma Health Science Center, Dept of Medicine/CardioVascular section | University of Oklahoma Health Sciences Center Dept of OB/GYN | University of Oklahoma Health Sciences Center, Oklahoma City, USA | University of Oklahoma HSC | University of Oklahoma HSC, Dept. of Urology | University of Oklahoma Medicine/Cardiovascular Section | University of Oklahoma, Oklahoma City, OK | University of Oklahoma-Tulsa | University of Oklohoma | VA Medical Center and University of Oklahoma
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1990Last known activity
Jan 5, 2026
Timeline
1890s
- Jan 1, 1890
University of Oklahoma— Founded
Drugs by trial phase (201 distinct, 192 trials)
Phase 4 (36 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (42 own, 0 via acquisition)
Other trials (41 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Anemia
- Anemia, Sickle Cell
- Anovulation
- Anxiety Disorders
- Atrial Fibrillation
- Attention Deficit Disorder with Hyperactivity
- Autistic Disorder
- Bipolar Disorder
- Breast Neoplasms
- Carcinoma
- Carcinoma, Endometrioid
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Transitional Cell
- Carcinosarcoma
- Cardiac Complexes, Premature
- Cardiovascular Diseases
- Cervical Intraepithelial Neoplasia
- Cholestasis
- Chronic Disease
- Communicable Diseases
- Coronary Artery Disease
- Coronavirus Infections
- Cystadenocarcinoma, Serous
- Deafness
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Disease
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Fetal Alcohol Spectrum Disorders
- Gastroesophageal Reflux
- Gastroschisis
- Glioblastoma
- Gonadal Dysgenesis
- Head and Neck Neoplasms
- Hearing Loss
- Hemophilia A
- Hemorrhage
- Hemorrhoids
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hernia, Inguinal
- Herpes Zoster
- HIV Infections
- Hyperkinesis
- Hypersensitivity
- Hypertension
- Hypertension, Pulmonary
- Hypoplastic Left Heart Syndrome
- Infant, Premature, Diseases
- Infections
- Infertility
- Infertility, Female
- Infertility, Male
- Insulin Resistance
- Intestinal Atresia
- Kidney Neoplasms
- Laron Syndrome
- Lung Injury
- Lymphoma
- Major Depressive Disorder
- Melanoma
- Mixed Tumor, Mullerian
- Mucositis
- Nausea
- Neoplasms
- Neutropenia
- Obesity
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Parkinson Disease
- Peritoneal Neoplasms
- Polycythemia
- Polycythemia Vera
- Postoperative Pain
- Pregnancy, Ectopic
- Premature Birth
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Purpura, Thrombotic Thrombocytopenic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Diseases
- Retinopathy of Prematurity
- Severe Acute Respiratory Syndrome
- Short Bowel Syndrome
- Squamous Intraepithelial Lesions of the Cervix
Recent trials (50)
- NCT07099638Lead sponsorPhase 2Jan 5, 2026
- NCT07099638CollaboratorPhase 2Jan 5, 2026
- NCT07223541OfficialPhase 2Dec 31, 2025
- NCT07223541Lead sponsorPhase 2Dec 31, 2025
- NCT07200544Lead sponsorPhase 4Nov 30, 2025
- NCT07146893Lead sponsorEarly Phase 1Nov 30, 2025
- NCT07224282Lead sponsorEarly Phase 1Nov 17, 2025
- NCT07183319OfficialPhase 2Oct 31, 2025
- NCT07183319Lead sponsorPhase 2Oct 31, 2025
- NCT07007195CollaboratorEarly Phase 1Oct 17, 2025
- NCT06861920CollaboratorPhase 4Apr 30, 2025
- NCT06245083Lead sponsorEarly Phase 1Dec 31, 2024
- NCT06245083OfficialEarly Phase 1Dec 31, 2024
- NCT06660017Lead sponsorPhase 2Nov 30, 2024
- NCT06660017OfficialPhase 2Nov 30, 2024
Details
- Founded
- Norman, OK, US Jan 1, 1890
- Last known activity
- Jan 5, 2026